Novo Nordisk Expands Cell Therapy Partnership with Aspect Biosystems for Diabetes
Novo Nordisk has expanded its collaboration with Aspect Biosystems to accelerate the development of cell-based therapies for diabetes, strengthening a […]
ASPECT-BIOSYSTEMS
